The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for stage III colon cancer patients who underwent curative resection (KSCC1303).
 
Nobutomo Miyanari
No Relationships to Disclose
 
Yasunori Emi
No Relationships to Disclose
 
Akihito Tsuji
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical
 
Kenji Sakai
No Relationships to Disclose
 
Hideaki Anai
No Relationships to Disclose
 
Hiroaki Takeshita
No Relationships to Disclose
 
Hiroshi Imamura
No Relationships to Disclose
 
Shinichiro Mori
No Relationships to Disclose
 
Takayuki Shimose
No Relationships to Disclose
 
Eiji Oki
No Relationships to Disclose
 
Hiroshi Saeki
No Relationships to Disclose
 
Yoshihiro Kakeji
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Yoshito Akagi
No Relationships to Disclose
 
Hideo Baba
No Relationships to Disclose
 
Yoshihiko Maehara
No Relationships to Disclose